• Home
  • Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd.

Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd.

About Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd.

Founded in 2013, Nanjing Heron Pharmaceutical Science & Technology Company Limited is an innovation-oriented company engaged in the research, development and industrial production of new drugs and first-time generic drugs in China. Active Vitamin D derivatives synthesis and Regulatory Service with Technical Support are the two critical characteristics of Heron Pharma. In 2016, Heron Pharma successfully landed on the NEEQ Stock market (National Equities Exchange and Quotations, Stock Code: 870070). We established a GMP-certified production site for the scale-up and industrial produc...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2019
    On CPHI since
View company profile
Contact info
  • +86 150 2187 4276
  • Website
  • Room 1903, Building 20, No. 1679 Yuqiao Road, Pudong New Area District,, 201204, Shangai, China
Show contact info Hide contact info
Meet us at

CPHI & PMEC China 2025

Shanghai New International Expo Center
24 Jun 2025 - 26 Jun 2025
View Exhibitor Profile

Products from Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd. (30)

  • Dexlansoprazole Sodium

    Product Dexlansoprazole Sodium

    produced under GMP conditions, indicated for Gastric ulcer, duodenal ulcer and reflux esophagitis
  • Calcifediol

    Product Calcifediol

    in compliance with the monographs of USP/EP/BP, produced under GMP conditions, indicated for Osteoporosis, Rickets and Osteomalacia.
  • Maxacalcitol

    Product Maxacalcitol

    produced under GMP conditions, indicated for Secondary hyperparathyroidism and Psoriasis
  • Calcitriol

    Product Calcitriol

    Calcitriol (骨化三醇)  in compliance with BP/USP/EP monographs, produced under GMP conditions, indicated for Rickets, Osteoporosis, Hypoparathyroidism, Renal osteodystrophy and Osteomalacia.
  • Alfacalcidol

    Product Alfacalcidol

    Alfacalcidol (阿法骨化醇) is in compliance with the monographs of EP/BP/ChP Grade, produced under GMP conditions and indicated for Osteoporosis, Chronic renal insufficiency, Hypoparathyroidism, Vitamin D-resistant rickets and Osteomalacia.
  • Calcipotriol monohydrate

    Product Calcipotriol monohydrate

    EP/BP Grade, produced under GMP conditions, indicated for Psoriasis Vulgaris.
  • Doxercalciferol

    Product Doxercalciferol

    in compliance with Monograph of USP, produced under GMP conditions and indicated for Secondary hyperparathyroidism
  • Eldecalcitol

    Product Eldecalcitol

    Produced under GMP conditions, indicated for Osteoporosis
  • Paricalcitol

    Product Paricalcitol

     USP grade, produced under GMP conditions and indicated for Secondary hyperparathyroidism
  • Tacalcitol Monohydrate

    Product Tacalcitol Monohydrate

    in compliance with the monographs of EP/JP, produced under GMP conditions and indicated for Psoriasis Vulgaris
  • Bisacodyl

    Product Bisacodyl

    ChP Grade, produced under GMP conditions with China Drug License
  • Bisacodyl Enteric-coated Tablets (5mg)

    Product Bisacodyl Enteric-coated Tablets (5mg)

    8 or16 tablets/blister, GMP production with China's Drug License
show all 30 products

Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd. Resources (3)